Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3RZ3

Human Cdc34 E2 in complex with CC0651 inhibitor

3RZ3 の概要
エントリーDOI10.2210/pdb3rz3/pdb
関連するPDBエントリー2OB4
分子名称Ubiquitin-conjugating enzyme E2 R1, 4,5-dideoxy-5-(3',5'-dichlorobiphenyl-4-yl)-4-[(methoxyacetyl)amino]-L-arabinonic acid (3 entities in total)
機能のキーワードubiquitin conjugating enzyme domain, e2 domain, ligase-ligase inhibitor complex, ligase/ligase inhibitor
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm: P49427
タンパク質・核酸の鎖数4
化学式量合計84807.14
構造登録者
Ceccarelli, D.F.,Webb, D.R.,Sicheri, F. (登録日: 2011-05-11, 公開日: 2011-07-06, 最終更新日: 2024-11-06)
主引用文献Ceccarelli, D.F.,Tang, X.,Pelletier, B.,Orlicky, S.,Xie, W.,Plantevin, V.,Neculai, D.,Chou, Y.C.,Ogunjimi, A.,Al-Hakim, A.,Varelas, X.,Koszela, J.,Wasney, G.A.,Vedadi, M.,Dhe-Paganon, S.,Cox, S.,Xu, S.,Lopez-Girona, A.,Mercurio, F.,Wrana, J.,Durocher, D.,Meloche, S.,Webb, D.R.,Tyers, M.,Sicheri, F.
An allosteric inhibitor of the human cdc34 ubiquitin conjugating enzyme
Cell(Cambridge,Mass.), 145:1075-1087, 2011
Cited by
PubMed Abstract: In the ubiquitin-proteasome system (UPS), E2 enzymes mediate the conjugation of ubiquitin to substrates and thereby control protein stability and interactions. The E2 enzyme hCdc34 catalyzes the ubiquitination of hundreds of proteins in conjunction with the cullin-RING (CRL) superfamily of E3 enzymes. We identified a small molecule termed CC0651 that selectively inhibits hCdc34. Structure determination revealed that CC0651 inserts into a cryptic binding pocket on hCdc34 distant from the catalytic site, causing subtle but wholesale displacement of E2 secondary structural elements. CC0651 analogs inhibited proliferation of human cancer cell lines and caused accumulation of the SCF(Skp2) substrate p27(Kip1). CC0651 does not affect hCdc34 interactions with E1 or E3 enzymes or the formation of the ubiquitin thioester but instead interferes with the discharge of ubiquitin to acceptor lysine residues. E2 enzymes are thus susceptible to noncatalytic site inhibition and may represent a viable class of drug target in the UPS.
PubMed: 21683433
DOI: 10.1016/j.cell.2011.05.039
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 3rz3
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon